Memantin Basics

Memantine, the active ingredient in Memantin Basics, is a NMDA receptor antagonist presented as an oral formulation for oral use. It is indicated for the symptomatic treatment of Alzheimer’s disease in adults.

GNH USA supplies Memantin Basics as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Memantin Basics is an NMDA receptor antagonist used in the management of Alzheimer’s disease and its related symptoms. - Alzheimer’s disease (moderate to severe): helps maintain cognition and daily functioning. - Cognitive decline in Alzheimer’s disease: may slow the worsening of memory and thinking. - Behavioral disturbances in Alzheimer’s disease: can reduce agitation and aggression.

Memantin Basics may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects: - Dizziness - Headache - Constipation - Confusion - Hypertension - Insomnia

Serious or Rare Side Effects: - Seizures - Severe skin rash or Stevens‑Johnson syndrome - Hepatic injury - Suicidal thoughts or behavior - Psychosis - Cardiac arrhythmias

When prescribing Memantin Basics, several safety considerations should be observed. - Renal impairment: dose adjustment may be required. - Hepatic impairment: use with caution and monitor liver function. - History of seizures: monitor closely for increased seizure activity. - Concomitant use with other NMDA antagonists: avoid additive neurotoxicity. - Pregnancy: safety not established; avoid unless clearly needed. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Memantin Basics can interact with other medicines, requiring attention to the level of interaction.

Major Interactions (Avoid): - Amantadine: increased risk of neurotoxicity. - Other NMDA antagonists (e.g., ketamine): additive central nervous system effects. - Strong CYP450 inhibitors (e.g., ketoconazole): may raise memantine plasma concentrations.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may diminish therapeutic benefit. - Diuretics: can enhance dizziness or hypotension. - Alcohol: may potentiate central nervous system depression.